RhumbLine Advisers
TMDX icon

RhumbLine Advisers’s Transmedics TMDX Stock Holding History

RhumbLine Advisers’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.33M Sell
80,220
-9,604
-11% -$813K ﹤0.01% 1432
2026
Q1 		$8.93M Buy
89,824
+1,788
+2% +$233K 0.01% 1114
2025
Q4 		$10.7M Sell
88,036
-5,306
-6% -$666K 0.01% 1030
2025
Q3 		$10.5M Buy
93,342
+125
+0.1% +$14.6K 0.01% 1062
2025
Q2 		$12.5M Buy
93,217
+3,693
+4% +$405K 0.01% 960
2025
Q1 		$6.02M Sell
89,524
-537
-0.6% -$36.9K 0.01% 1260
2024
Q4 		$5.62M Buy
90,061
+23,742
+36% +$2.21M 0.01% 1367
2024
Q3 		$10.4M Buy
66,319
+18,674
+39% +$2.88M 0.01% 1026
2024
Q2 		$7.18M Buy
47,645
+1,783
+4% +$214K 0.01% 1189
2024
Q1 		$3.39M Buy
45,862
+301
+0.7% +$24.8K ﹤0.01% 1621
2023
Q4 		$3.6M Sell
45,561
-1,034
-2% -$62.4K ﹤0.01% 1602
2023
Q3 		$2.55M Buy
46,595
+1,123
+2% +$80.8K ﹤0.01% 1743
2023
Q2 		$3.82M Buy
45,472
+3,016
+7% +$231K ﹤0.01% 1540
2023
Q1 		$3.21M Buy
42,456
+2,421
+6% +$167K ﹤0.01% 1568
2022
Q4 		$2.47M Buy
40,035
+3,852
+11% +$205K ﹤0.01% 1674
2022
Q3 		$1.51M Buy
36,183
+5,234
+17% +$228K ﹤0.01% 1928
2022
Q2 		$973K Buy
30,949
+5,744
+23% +$153K ﹤0.01% 2156
2022
Q1 		$679K Buy
25,205
+1,621
+7% +$29K ﹤0.01% 2283
2021
Q4 		$452K Sell
23,584
-371
-2% -$9.3K ﹤0.01% 2550
2021
Q3 		$793K Buy
23,955
+1,166
+5% +$35.6K ﹤0.01% 2339
2021
Q2 		$756K Sell
22,789
-651
-3% -$18K ﹤0.01% 2371
2021
Q1 		$973K Sell
23,440
-886
-4% -$27.3K ﹤0.01% 2201
2020
Q4 		$484K Buy
24,326
+2,804
+13% +$41.5K ﹤0.01% 2457
2020
Q3 		$297K Buy
21,522
+214
+1% +$3.67K ﹤0.01% 2524
2020
Q2 		$382K Buy
21,308
+8,080
+61% +$126K ﹤0.01% 2454
2020
Q1 		$160K Buy
13,228
+2,371
+22% +$39.7K ﹤0.01% 2655
2019
Q4 		$206K Buy
+10,857
New +$199K ﹤0.01% 2736

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

RhumbLine Advisers's TMDX Position: Q2 2026 in Review

RhumbLine Advisers reduced its Transmedics (TMDX) stake by 11% in Q2 2026, selling an estimated $813K and leaving 80,220 shares worth $5.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1432.

RhumbLine Advisers first reported a position in TMDX in Q4 2019 and has held it in 27 quarters since. The position peaked at $12.5M in Q2 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • RhumbLine Advisers held 80,220 shares of Transmedics worth $5.33M as of Q2 2026.
  • RhumbLine Advisers sold 9,604 Transmedics shares in Q2 2026, an estimated $813K.
  • Transmedics made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1432 holding.
  • RhumbLine Advisers first reported a position in Transmedics in Q4 2019 and has held it in 27 quarters since.
  • RhumbLine Advisers's Transmedics position peaked at $12.5M in Q2 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.